Old Web
English
Sign In
Acemap
>
authorDetail
>
Brenda Jesernig
Brenda Jesernig
Fred Hutchinson Cancer Research Center
Cancer research
T cell
Antigen
CD8
Melanoma
5
Papers
91
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells
2021
Journal of Clinical Investigation
Joshua R. Veatch
Naina Singhi
Shivani Srivastava
Julia L. Szeto
Brenda Jesernig
Sylvia M. Stull
Matthew Fitzgibbon
Megha Sarvothama
Sushma Yechan-Gunja
Scott E. James
Stanley R. Riddell
Show All
Source
Cite
Save
Citations (1)
Endogenous CD4+ T cells recognize neoantigens in lung cancer patients, including recurrent oncogenic KRAS and ERBB2 (Her2) driver mutations
2019
Cancer immunology research
Joshua R. Veatch
Brenda Jesernig
Julia Kargl
Matthew Fitzgibbon
Sylvia M. Lee
Christina S. Baik
Renato Martins
A. McGarry Houghton
Stanley R. Riddell
Show All
Source
Cite
Save
Citations (35)
Isolation of CD4+ T cells specific for neoantigens created by recurrent driver mutations in non-small cell lung cancer (NSCLC) and melanoma.
2018
Journal of Clinical Oncology
Joshua R. Veatch
Brenda Jesernig
Sylvia M. Lee
Matthew Fitzgibbon
A. McGarry Houghton
Stanley R. Riddell
Show All
Source
Cite
Save
Citations (0)
1